Shuwen Biotech’s Clinical Lab Receives Accreditation from College of American Pathologists
Deqing, China, September 23, 2016 — Shuwen Biotech Co. Ltd., a China-based diagnostic company focused on licensing, developing and commercializing diagnostic kits and services for unmet clinical needs, has announced today that the Accreditation Committee of the College of American Pathologists (CAP) has awarded accreditation to its China-based clinical laboratories Shuwen Guanz Diagnostic Lab Co., Ltd. based on results of a recent on-site inspection as part of the CAP’s Accreditation Programs.
“We are delighted to have received CAP accreditation,” said Saaras Hu, Chief Operating Officer of Shuwen Guanz Diagnostic Lab Co., Ltd. “As a leading clinical diagnostic reference lab in China, we strive to maintain the highest quality standard and provide the best diagnostic services to our customers. CAP accreditation attests our effort.”
Jay Z. Zhang, Chairman and CEO of Shuwen Biotech Co. Ltd. added: “We have provided clinical testing services to Chinese physicians. We have also provided companion diagnostic development services to pharmaceutical companies. CAP accreditation is a validation of our molecular diagnostic capabilities and allows us to expand our services internationally in clinical testing for both hospitals and pharmaceutical companies.”
The U.S. federal government recognizes the CAP Laboratory Accreditation Program, begun in the early 1960s, as being equal-to or more-stringent-than the government’s own inspection program.
During the CAP accreditation process, designed to ensure the highest standard of care for all laboratory patients, inspectors examine the laboratory’s records and quality control of procedures for the preceding two years. CAP inspectors also examine laboratory staff qualifications, equipment, facilities, safety program and record, and overall management.
About Shuwen Biotech Co. Ltd.
Based in China and led by U.S. diagnostic industry veterans, Shuwen Biotech is an integrated diagnostic company engaged in licensing, developing, marketing and distributing innovative products and services for disease diagnosis and personalized medicine. The company strives to provide China’s doctors and their patients with a comprehensive menu of the most innovative diagnostic products and services for improved disease prediction, screening, diagnosis, prognosis and treatment. Shuwen offers, in China, diagnostic kits and diagnostic services for disease prevention and personalized medicine in cancer and other diseases. More information about Shuwen Biotech Co. Ltd. can be found at www.shuwenbiotech.com and www.shuwendx.cn.
About the College of American Pathologists
As the leading organization with more than 18,000 board-certified pathologists, the College of American Pathologists (CAP) serves patients, pathologists, and the public by fostering and advocating excellence in the practice of pathology and laboratory medicine worldwide. The CAP’s Laboratory Improvement Programs, initiated 65 years ago, currently have customers in more than 100 countries, accrediting 7,700 laboratories and providing proficiency testing to 20,000 laboratories worldwide. Find more information about the CAP at cap.org. Follow CAP on Twitter: @pathologists.